Forte Biosciences Inc
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | 0.15 | 0.14 | 0.14 | 0.14 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.03 | 0.02 | 0.02 | – | – | – | – | – | – | – | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | |
| – | – | – | – | – | – | – | – | 0.15 | – | – | 0.14 | 0.14 | – | – | – | -0.03 | -0.02 | -0.02 | – | – | – | – | – | – | – | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | |
| 112.51 | 152.29 | 143.17 | 156.84 | 196.60 | 240.24 | 230.48 | 286.36 | 14.05 | 4.91 | 5.54 | 119.19 | 21.24 | 13.27 | 16.75 | 5.89 | 6.27 | 6.47 | 9.91 | 2.29 | 1.17 | 1.75 | 1.82 | 2.96 | 5.70 | 8.48 | 4.21 | 0.10 | 2.80 | 3.11 | 3.10 | 0.82 | 1.10 | 0.73 | 0.85 | 1.20 | 1.14 | 0.01 | 2.39 | |
| 32.95 | 46.61 | 41.34 | 45.44 | 45.57 | 48.43 | 81.20 | 64.11 | 5.27 | 5.05 | 5.19 | 48.88 | 10.56 | 5.20 | 5.99 | 2.86 | 2.68 | 4.09 | 3.59 | 3.30 | 3.08 | 3.36 | 2.70 | 2.92 | 2.46 | 2.25 | 2.54 | 0.08 | 2.22 | 3.84 | 1.49 | 0.33 | 0.30 | 0.25 | 0.18 | 0.16 | 0.11 | 0.10 | 0.43 | |
| 145.47 | 198.90 | 184.51 | 202.28 | 242.17 | 288.67 | 311.67 | 350.48 | 19.29 | 9.96 | 10.73 | 145.49 | 31.80 | 238.02 | 22.74 | 8.75 | 8.94 | 10.56 | 13.50 | 5.59 | 4.26 | 5.11 | 4.52 | 5.88 | 8.16 | 10.73 | 6.74 | 0.18 | 5.02 | 6.94 | 4.66 | 1.15 | 1.41 | 0.98 | 1.03 | 1.38 | 1.26 | 1.03 | 3.78 | |
| -145.28 | -198.67 | -184.33 | -202.09 | -242.00 | -288.50 | 26.82 | -350.31 | -19.32 | -9.96 | -10.73 | -145.35 | -31.80 | -238.02 | -22.74 | -8.75 | -8.94 | -10.56 | -13.52 | -5.59 | -4.26 | -5.11 | -4.52 | -5.88 | -8.16 | -10.73 | -6.75 | -0.18 | -5.02 | -6.95 | -4.67 | -1.15 | -1.41 | -0.99 | -1.03 | -1.38 | -1.26 | -1.03 | -3.78 | |
| 10.46 | 11.37 | 8.14 | 7.39 | 6.57 | 20.57 | 13.95 | 13.81 | 3.47 | 12.10 | 30.96 | 2.09 | 11.86 | – | – | – | – | – | – | 0.07 | 0.09 | 0.03 | 0.03 | 0.01 | 0.12 | – | – | 0.00 | 0.07 | – | – | – | – | – | – | – | – | – | – | |
| -154.11 | -208.18 | -188.41 | -204.92 | -242.64 | -302.85 | 21.16 | -355.92 | -19.29 | -9.98 | -10.83 | -166.06 | -32.16 | -238.06 | -23.16 | -8.92 | -9.06 | -10.68 | -13.61 | -5.66 | -4.35 | -5.14 | -4.49 | -5.81 | -8.04 | -10.57 | -6.57 | -0.16 | -4.77 | -6.78 | -4.54 | -1.12 | -1.37 | -0.96 | -0.99 | -1.33 | -1.22 | -0.97 | -3.63 | |
| – | – | – | – | – | – | 28.36 | 58.82 | -6.93 | -3.44 | -10.73 | 0.02 | 0.02 | 219.54 | – | – | – | – | – | 0.07 | 0.09 | 0.03 | -0.03 | 0.01 | -0.12 | -0.01 | 0.00 | 0.00 | -0.02 | – | – | 0.01 | – | – | – | 0.06 | 0.02 | 0.01 | – | |
| -154.11 | -208.18 | -188.41 | -204.92 | -242.64 | -302.85 | 49.53 | -414.74 | -19.29 | -9.98 | -10.83 | -166.06 | -32.16 | -238.06 | -23.16 | -8.92 | -9.06 | -10.68 | -13.61 | -5.66 | -4.35 | -5.17 | -4.49 | -5.81 | -8.04 | -10.57 | -6.57 | -0.16 | -4.77 | -6.78 | -4.54 | -1.12 | -1.37 | -0.96 | -0.99 | -1.39 | -1.24 | -0.98 | -3.70 | |
| -142.53 | -195.39 | -178.97 | -195.72 | -235.15 | -279.88 | 38.85 | -332.78 | -278.00 | -9.96 | -10.73 | -157.96 | -31.60 | -18.37 | -22.69 | -8.73 | -8.92 | -10.66 | -13.59 | -5.66 | -4.35 | -5.10 | -4.49 | -5.79 | -8.04 | 0.16 | -6.57 | -0.18 | -4.77 | -6.77 | -4.54 | -1.12 | -1.37 | -0.96 | -0.99 | -1.33 | -1.22 | -0.97 | -3.63 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.